Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haemocomplettan for dilutional coagulopathy in pediatric surgery
NCT01487837Phase 4Completed
- Sponsor
- Kinderspital Zürich
- Start
- Jan 2012
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Fibrinogen human in dilutional coagulopathy, sponsored by Kinderspital Zürich. Primary endpoint: Total amount of transfused red cell concentrate at 24 hours. Started Jan 2012; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
dilutional coagulopathy
Beyond the preview
Go deeper on NCT01487837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01487837.